NCT07020494View on ClinicalTrials.gov

A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 25, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Self-reported Memory ProblemsMemory
Interventions
DIETARY_SUPPLEMENT

Lipase Thera-blend

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

DIETARY_SUPPLEMENT

Lipase Thera-blend + tributyrin

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

OTHER

Placebo

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

Trial Locations (1)

N6B3L1

RECRUITING

KGK Science Inc., London

Sponsors

Lead Sponsor

Enzymedica

Collaborators (1)

KGK Science Inc.
All Listed Sponsors
collaborator

KGK Science Inc.

INDUSTRY

lead

Enzymedica

INDUSTRY

NCT07020494 - A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems | Biotech Hunter | Biotech Hunter